FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients. [electronic resource]
Producer: 20180305Description: 63 p. digitalISSN:- 1756-9966
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor
- Carcinoma, Ovarian Epithelial
- Cell Line, Tumor
- Cell Movement
- Cell Proliferation
- Cell Transformation, Neoplastic -- genetics
- Cystadenocarcinoma, Serous -- genetics
- DNA Repair
- Disease Progression
- Drug Resistance, Neoplasm -- genetics
- Female
- Forkhead Box Protein M1 -- genetics
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Gene Knockdown Techniques
- Humans
- Kaplan-Meier Estimate
- Middle Aged
- Neoplasm Grading
- Neoplasm Metastasis
- Neoplasm Staging
- Neoplasms, Glandular and Epithelial -- drug therapy
- Ovarian Neoplasms -- drug therapy
- Prognosis
- Protein Isoforms
- RNA, Small Interfering -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.